Literature DB >> 16344552

Glucose-stimulated DNA synthesis through mammalian target of rapamycin (mTOR) is regulated by KATP channels: effects on cell cycle progression in rodent islets.

Guim Kwon1, Connie A Marshall, Hui Liu, Kirk L Pappan, Maria S Remedi, Michael L McDaniel.   

Abstract

The aim of this study was to define metabolic signaling pathways that mediate DNA synthesis and cell cycle progression in adult rodent islets to devise strategies to enhance survival, growth, and proliferation. Since previous studies indicated that glucose-stimulated activation of mammalian target of rapamycin (mTOR) leads to [3H]thymidine incorporation and that mTOR activation is mediated, in part, through the K(ATP) channel and changes in cytosolic Ca2+, we determined whether glyburide, an inhibitor of K(ATP) channels that stimulates Ca2+ influx, modulates [3H]thymidine incorporation. Glyburide (10-100 nm) at basal glucose stimulated [3H]thymidine incorporation to the same magnitude as elevated glucose and further enhanced the ability of elevated glucose to increase [3H]thymidine incorporation. Diazoxide (250 microm), an activator of KATP channels, paradoxically potentiated glucose-stimulated [3H]thymidine incorporation 2-4-fold above elevated glucose alone. Cell cycle analysis demonstrated that chronic exposure of islets to basal glucose resulted in a typical cell cycle progression pattern that is consistent with a low level of proliferation. In contrast, chronic exposure to elevated glucose or glyburide resulted in progression from G0/G1 to an accumulation in S phase and a reduction in G2/M phase. Rapamycin (100 nm) resulted in an approximately 62% reduction of S phase accumulation. The enhanced [3H]thymidine incorporation with chronic elevated glucose or glyburide therefore appears to be associated with S phase accumulation. Since diazoxide significantly enhanced [3H]thymidine incorporation without altering S phase accumulation under chronic elevated glucose, this increase in DNA synthesis also appears to be primarily related to an arrest in S phase and not cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16344552     DOI: 10.1074/jbc.M508821200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  mTORC1 activation regulates beta-cell mass and proliferation by modulation of cyclin D2 synthesis and stability.

Authors:  Norman Balcazar; Aruna Sathyamurthy; Lynda Elghazi; Aaron Gould; Aaron Weiss; Ichiro Shiojima; Kenneth Walsh; Ernesto Bernal-Mizrachi
Journal:  J Biol Chem       Date:  2009-01-14       Impact factor: 5.157

2.  Therapeutic Strategies to Increase Human β-Cell Growth and Proliferation by Regulating mTOR and GSK-3/β-Catenin Pathways.

Authors:  Nidhi Rohatgi; Maria S Remedi; Guim Kwon; Kirk L Pappan; Connie A Marshall; Michael L McDaniel
Journal:  Open Endocrinol J       Date:  2010

3.  ATP-independent glucose stimulation of sphingosine kinase in rat pancreatic islets.

Authors:  L D Mastrandrea; S M Sessanna; A Del Toro; S G Laychock
Journal:  J Lipid Res       Date:  2010-04-05       Impact factor: 5.922

4.  Non-invasive imaging of PI3K/Akt/mTOR signalling in cancer.

Authors:  Snehal M Gaikwad; Pritha Ray
Journal:  Am J Nucl Med Mol Imaging       Date:  2012-10-15

5.  Synaptic stimulation of mTOR is mediated by Wnt signaling and regulation of glycogen synthetase kinase-3.

Authors:  Tao Ma; Nikos Tzavaras; Panayiotis Tsokas; Emmanuel M Landau; Robert D Blitzer
Journal:  J Neurosci       Date:  2011-11-30       Impact factor: 6.167

6.  Sirolimus is associated with new-onset diabetes in kidney transplant recipients.

Authors:  Olwyn Johnston; Caren L Rose; Angela C Webster; John S Gill
Journal:  J Am Soc Nephrol       Date:  2008-04-02       Impact factor: 10.121

7.  Critical roles for the TSC-mTOR pathway in β-cell function.

Authors:  Hiroyuki Mori; Ken Inoki; Darren Opland; Heike Münzberg; Eneida C Villanueva; Miro Faouzi; Tsuneo Ikenoue; David J Kwiatkowski; Ormond A Macdougald; Martin G Myers; Kun-Liang Guan
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-08-18       Impact factor: 4.310

8.  Rapamycin inhibits growth factor-induced cell cycle regulation in pancreatic beta cells.

Authors:  Amy Aronovitz; Jami Josefson; Amanda Fisher; Marsha Newman; Elizabeth Hughes; Fei Chen; David S Moons; Hiroaki Kiyokawa; William L Lowe
Journal:  J Investig Med       Date:  2008-12       Impact factor: 2.895

9.  Glibenclamide activates translation in rat pancreatic beta cells through calcium-dependent mTOR, PKA and MEK signalling pathways.

Authors:  Q Wang; H Heimberg; D Pipeleers; Z Ling
Journal:  Diabetologia       Date:  2008-05-21       Impact factor: 10.122

10.  An intermediate-conductance Ca(2+)-activated K (+) channel mediates B lymphoma cell cycle progression induced by serum.

Authors:  Jing Wang; Yu-Qing Xu; You-You Liang; Rafael Gongora; David G Warnock; He-Ping Ma
Journal:  Pflugers Arch       Date:  2007-04-12       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.